Perceptions, Attitudes and Barriers to Obesity Management in Pakistan: Country‐Specific Analysis From the ACTION‐APAC Study Authors: Asma Ahmed, A. H. Aamir, Muslim Atiq, Mohammad Imtiaz Hasan, Zahid Miyan, Kashif Shafique, Atika Shaheer, Muhammad Aleem Zahir, Amber Hussain Published: 2026 Background Obesity is a chronic, potentially progressive disease that has reached epidemic proportions across the Asia‐Pacific (APAC) region [1]. Pakistan, with an estimated population of approximately 255 million, has one of the largest obesity burdens in South Asia. Based on Asia‐specific body mass index (BMI) cut‐off (obesity: BMI ≥ 25 kg/m2), approximately 150.6 million people (6 in 10 individuals) are estimated to be living with obesity in Pakistan [2, 3, 4]. Despite this burden, obesity remains underdiagnosed and undertreated, partly due to limited recognition as a chronic disease requiring structured and coordinated management [5]. The awareness, care and treatment in obesity management (ACTION) studies were designed to assess perceptions, attitudes, behaviors, and barriers among people with obesity (PwO) and healthcare professionals (HCPs) [6, 7, 8]. Considering the distinct cultural and socioeconomic context, current, nationally focused data on how PwO and HCPs in Pakistan perceive obesity and its management have not been reported. This Pakistan‐specific analysis provides a baseline against which continuing medical education programs and the timely, appropriate management of obesity can be assessed. Methods ACTION‐APAC was a cross‐sectional descriptive study conducted via an online survey of PwO and HCPs in nine countries (April–May 2022) to characterise perceptions, attitudes, behaviors, and barriers related to obesity care [8]. In Pakistan, PwO aged ≥ 18 years with self‐reported BMI ≥ 25 kg/m2 [4] were included; those pregnant or engaged in intense fitness or bodybuilding programs were excluded. HCPs were physicians with ≥ 2 years of practice who managed > 100 patients/month, including ≥ 10 with obesity. Surveys were offered in English, Hindi and Urdu. Participants were recruited through online panels, with additional telephonic and in‐person recruitment for HCPs. PwO were demographically weighted using a ranking technique, with weights capped at 0.5 and 5.00 to avoid extreme design effects. Agreement type responses were assessed using a 5‐point Likert scale, ranging from 1 = strongly disagree to 5 = strongly agree. Data were analysed descriptively. Results Sample Characteristics PwO (n = 931) had a mean ± SD age of 33.0 ± 10.5 years; 51% were female, 79% resided in urban areas, and most had class 1 (46%) and class 2 (36%) obesity. Among HCPs (n = 200), 77% were male, with a mean ± SD of 9.1 ± 2.7 years in practice; 97% considered themselves obesity experts and reported receiving advanced training (Table S1). Self‐Perceptions and Readiness to Change One‐third of PwO perceived themselves as having obesity, while 65% described their weight as overweight or normal (Figure S1A). Most participants (n = 596; 64%) acknowledged that 5%–10% weight loss (WL) would be beneficial for overall health; 33% were committed to taking action to achieve WL. PwO began struggling with weight at a mean age of 25.0 years and took 3 years before discussing it with HCPs. Motivation for WL was driven by improving fitness (n = 335; 36%), increasing energy levels (n = 326; 35%), addressing general health concerns (n = 242; 26%), and improving self‐esteem (n = 242; 26%) (Figure S2). PwO reported a mean of two serious WL attempts, and 44% regained weight; the main reasons were discontinuing diet or exercise (48% each). Obesity Awareness and Attitudes Most PwO (65%) and HCPs (74%) recognized obesity as a chronic disease (Figure 1A), with 70%–76% of PwO rating it as serious as or more serious than diabetes, cancer, and COPD. However, 66% of PwO and 67% of HCPs believed that WL is completely the individual's responsibility (Table 1, also see key gaps identified; Figure S3). PwO identified lack of exercise (62%), unhealthy eating habits (49%), and high‐carbohydrate diets (48%) as top barriers to WL (Figure S4). After a weight loss attempt, more than half of PwO reported reverting to their usual eating habits, while 41% reported feeling controlled by their weight. Weight stigma was prominent, affecting romantic relationships (76%) and job prospects (67%) (Figure S5). Obesity perceptions, healthcare interactions and medication attitudes among PwO and HCPs: Pakistan ACTION‐APAC cohort (PwO, n = 931; HCPs, n = 200) #HCP responses not applicable. Bars show the proportion of respondents who selected 4 = agree or 5 = strongly agree on the 5‐point Likert scale. (Panel A) Obesity perceptions and attitudes: (i) obesity is a chronic disease (PwO 65%, HCP 74%); (ii) WL is completely my/their responsibility (PwO 66%, HCP 67%); (iii) could lose weight if set mind to it (PwO 66%, HCP 70%); (iv) obesity has extreme health impact (PwO 60%, HCP 83%); (v) easy for me/them to lose weight (PwO 38%, HCP 69%). (Panel B) HCP Interactions: (i) Discussed weight with HCP in past 5 years (PwO 36%); (ii) PwO initiates weight discussion (PwO 61%, HCP says HCP initiates 58%); (iii) received obesity diagnosis (PwO 66%); (iv) follow‐up scheduled (PwO 68%, HCP 45%); (v) top reason for not discussing: my own responsibility (PwO 42%). (Panel C) Medication attitudes: (i) rather lose weight myself than depend on medication (PwO 59%); (ii) concerned about OMM side effects (PwO 50%, HCP 63%); (iii) concerned about long‐term OMM safety (PwO 45%, HCP 68%); (iv) currently using prescription WL medication (PwO 7%); (v) trust HCP to recommend OMM (PwO 39%, HCP 66%). HCP, healthcare professional; OMM, obesity management medication; PwO, people with obesity; WL, weight loss. TABLE 1Gaps in clinical care and patient‐centred barriers to obesity management: Pakistan ACTION‐APAC cohort.Key survey question/indicatorPwO (n = 931)HCP (n = 200)Key insight/gapClinical frame: Diagnosis and treatment gapsDiscussion of medical treatment options43%—Limited translation of diagnosis into structured treatment planningKey HCP‐reported barriers to obesity care—Time constraints, competing prioritiesSystem‐level limitations restrict care deliveryBariatric surgery uptake~2%–8%Rarely usedMinimal use of advanced interventions despite high disease burdenPatient‐centred frame: Self‐perception, stigma and readinessSelf‐identification as having obesity33%—Two‐thirds of PwO do not self‐identify, indicating under‐recognition of disease statusCommitted to weight loss33%—Low readiness despite awareness; gap between knowledge and actionAge at onset of weight struggle25 years—Early onset but delayed intervention; long gap before clinical engagementPerceived social impact of obesity (harder to form relationships, employment barriers)67%–76%9%–19%PwO perceive far greater stigma than HCPs acknowledgeImpact of obesity vs. other diseases70%–76% consider obesity equally/more serious75%–85% consider obesity equally/more seriousHigh awareness but poor clinical action Note: Data points presented in Figure 1 (obesity perceptions, HCP discussion rates, medication attitudes, pharmacotherapy use, and obesity management medication safety concerns) are not duplicated here. Additional data on support structures, information preferences, treatment patterns, weight loss methods, and weight regain are presented in Supporting Information.Abbreviations: HCP, healthcare professional; PwO, people with obesity. Gaps in clinical care and patient‐centred barriers to obesity management: Pakistan ACTION‐APAC cohort. Note: Data points presented in Figure 1 (obesity perceptions, HCP discussion rates, medication attitudes, pharmacotherapy use, and obesity management medication safety concerns) are not duplicated here. Additional data on support structures, information preferences, treatment patterns, weight loss methods, and weight regain are presented in Supporting Information. Abbreviations: HCP, healthcare professional; PwO, people with obesity. Interactions With HCPs Only 36% of PwO had discussed weight with an HCP in the past 5 years. Among these, 61% reported initiating the discussion, whereas HCPs reported initiating 58% of discussions. The most commonly cited reason for not discussing weight was the belief in self‐responsibility (42%) (Figure 1B). Among PwO who discussed weight, 66% received a formal diagnosis, and 68% scheduled follow‐up appointments. Weight Management Strategies Among PwO who made a WL effort (n = 643), 53% discussed dietary changes, and 50% discussed exercise with their HCPs (Figure S6). Two in five reported discussing medical treatment; only 7% reported using obesity management medications (OMMs); 12% engaged with obesity specialists; and 11% had behavioural therapy. Moreover, 45% of PwO and 68% of HCPs expressed concern about the long‐term safety of OMMs (Figure 1C and Figure S7). Support Structures Sources of weight‐management information for PwO included the internet (49%) and family/friends (48%); only 24% reported gathering information from their HCPs (Table S2). The most frequently cited information needs were healthy ways to lose weight (42%), exercise guidance (40%), and strategies to maintain weight loss (33%), whereas medical treatment options (17%) and HCP involvement (19%) were less frequently reported. Preferred support included physical activity programmes (30%), meal plans (28%), encouragement from family/friends (27%), digital tools for tracking diet/activity (27%), and motivational programmes (27%). Conclusions In Pakistan, 65% of PwO recognised obesity as a chronic disease, aligning with ACTION‐APAC pooled cohort [8] and country‐level reports from India (72%) [9], Thailand (74%) [10], and Vietnam (67%) [11]. However, HCP recognition was notably lower (74%) compared with the APAC analyses (pooled 84% [8]; Thailand 92% [10]; Malaysia 88% [12]; India 83% [9]; and Vietnam 80% [11]). Although all PwO had a self‐reported BMI of ≥ 25 kg/m2, only 33% described themselves as having obesity, indicating a gap in self‐awareness. This proportion was lower than the pooled estimate in APAC (54%) [8], and other APAC nations (Malaysia (41%) [12], Vietnam (56%) [11] and India (68%) [9]). Whereas 65% acknowledged that a 5%–10% weight loss would be beneficial, these findings collectively point to a clear knowledge‐to‐action gap. Overall, these findings highlight a critical barrier to weight management in Pakistan, driven by low patient self‐perception and comparatively weaker clinical advocacy. Both HCPs (67%) and PwO (66%) viewed weight loss as solely the individual's responsibility, representing a significantly higher attribution of individual blame compared to other APAC countries (APAC pooled cohort (41%) [8] and country analyses from Malaysia (44%) [12], Thailand (39%) [10], Vietnam (55%) [11], and India (19%) [9]). This shared perception reinforces a lifestyle‐only treatment model and reduces the drive for structured, multimodal obesity care. PwO in Pakistan reported a lower rate of weight discussion with HCP (36%), below the APAC pooled mean of 43% [8], and lower than reported rates for India (47%) [9], Thailand (49%) [10], Saudi Arabia (58%) [13], and ACTION‐IO (54%) [6]. Pakistan also reported a lower mean age at onset of weight struggle (25 years) compared with India (29 years) [9] and the APAC cohort (30 years) [8]. Among PwO who had discussed weight with an HCP, 61% reported initiating the conversation themselves, while HCPs reported initiating 58% of conversations, suggesting a communication gap similar to that observed in ACTION‐IO (PwO 46% vs. HCP‐reported 33% patient‐initiated) [6] and Thailand (47% vs. 61%) [10]. HCP‐initiated follow‐up scheduling (45%) was below the APAC mean (49%) [8]. Although this analysis was not designed to identify intervention thresholds, these findings support earlier routine screening, counselling, and education for obesity and weight management. Although 97% of HCPs described themselves as obesity experts, only half saw ≥ 50% of their patients for obesity management. At the same time, 63%–68% of HCPs expressed concern about OMMs side effects and long‐term safety, and similar concerns were reported by PwO (50% side effects; 45% long‐term safety). The use of OMMs was low (7%), consistent with other ACTION cohorts despite differences in healthcare financing (Malaysia, 10% [12]; Ireland, 10% [14]). This suggests that barriers to OMMs use are not limited to cost or availability alone (OMMs are largely out‐of‐pocket expenses in Pakistan at the time of the survey [April–May 2022]); attitudes towards medication, safety concerns, prescribing confidence, and training gaps are also important. The findings also predate the expansion of real‐world safety data on glucagon like peptide‐1 receptor agonists for weight management [15, 16]. Therefore, updated continuing medical education is needed to provide evidence on the safety and efficacy of OMMs, alongside evidence‐based management approaches for PwO. Public‐health messaging that positions obesity as a chronic disease, clarifies BMI thresholds using Asian‐specific cut‐offs, and reinforces that 5%–10% weight loss has meaningful benefits is urgently needed, particularly given that PwO begin struggling with weight at a mean age of 25 years but wait 3 years before discussing with an HCP. At the policy level, sugar taxes, stringent food regulation, obesity screening in primary care, integration of nutrition education into school curricula, and investment in active‐living infrastructure could help convert awareness into action. A primary limitation is that this study was conducted in 2022; since then, the approaches to obesity management have evolved. However, recent research suggests that perceptions and attitudes have remained the same [17]. Other limitations include a predominantly urban sample and self‐reported BMI. The cross‐sectional design limits causal inference and does not allow identification of independent predictors or intervention thresholds. In addition, online recruitment may have excluded individuals with limited digital literacy. Future prospective studies should adopt multivariable modelling to identify independent predictors of readiness to change, low self‐identification of obesity, delayed HCP discussion, and use of OMMs, and include a rural and regionally diverse Pakistani population with class 3 and 4 obesity. Nonetheless, these findings offer current, Pakistan‐specific insights relevant to countries with comparable socio‐economic and healthcare contexts. In conclusion, the coexistence of high disease awareness with self‐responsibility beliefs, coupled with low engagement and limited OMM utilisation, highlights a critical care gap. To our knowledge, these are the first national data on perceptions of obesity in Pakistan and provide an important management baseline against which future changes in clinical practice and policy can be assessed. Funding This study was funded by Novo Nordisk. Conflicts of Interest This study was sponsored by Novo Nordisk. The sponsor contributed to the study design and to the analysis, interpretation, and reporting of data in conjunction with the academic investigators. A.A., A.H.A. and M.A. have nothing to disclose related to this work. M.I.H. has received honoraria for lectures from Novo Nordisk, Getz Pharma, Ferozsons, and Nabi Qasim. Z.M. has received honoraria and lecture fees from Novo Nordisk, Getz Pharma, Hoechst, and Hilton. K.S. has received a research grant from PharmEVO and honoraria for speaking engagements from GETZ Pharma, Global Pharma, Martin Dow Pharmaceutical, and Abbott Laboratories; he declares no other conflicts of interest related to this manuscript. A.S., M.A.Z. and A.H. are employees of Novo Nordisk and hold shares in the company. All authors had full access to all data and accept final responsibility for the decision to submit. Supporting information Table S1: Key baseline demographics and characteristics. Table S2: Additional findings from the ACTION‐APAC Pakistan cohort: weight history, support structures, and HCP engagement. Figure S1A: Self‐perception of people with obesity (PwO) about their current weight, Pakistan PwO (n = 931). Figure S1B: Self‐perception of overall health by people with obesity (PwO), Pakistan PwO (n = 931). Figure S2: Motivators for weight loss reported by people with obesity (PwO) and healthcare providers (HCPs). Figure S3: Attitudes (frequency) towards weight loss reported by people with obesity (PwO) and healthcare providers (HCPs). Figure S4: Barriers of weight loss reported by people with obesity (PwO) and healthcare providers (HCPs). Figure S5: Weight stigma reported by people with obesity (PwO) and healthcare providers (HCPs). Figure S6: Methods for managing weight discussed with healthcare providers (HCPs), %. Figure S7: Attitudes towards weight loss medication reported by people with obesity (PwO) and healthcare providers (HCPs).